1. What vector was administered? Is it predominantly integrating
[retroviral, lentiviral, herpesvirus (latency and reactivation)], or non-integrating
(plasmid, adenoviral, AAV)?
Bạn đang xem 1. - CHAPTER 065 GENE THERAPY IN CLINICAL MEDICINE PART 5 PPT
